NO311168B1 - Lyosf¶rer omfattende gonadotropin, fremgangsmåte ved fremstilling derav og farmasöytisk preparat omfattende sådanne - Google Patents
Lyosf¶rer omfattende gonadotropin, fremgangsmåte ved fremstilling derav og farmasöytisk preparat omfattende sådanne Download PDFInfo
- Publication number
- NO311168B1 NO311168B1 NO19954320A NO954320A NO311168B1 NO 311168 B1 NO311168 B1 NO 311168B1 NO 19954320 A NO19954320 A NO 19954320A NO 954320 A NO954320 A NO 954320A NO 311168 B1 NO311168 B1 NO 311168B1
- Authority
- NO
- Norway
- Prior art keywords
- gonadotropin
- lyospheres
- lyosphere
- freeze
- fsh
- Prior art date
Links
- 102000006771 Gonadotropins Human genes 0.000 title claims description 20
- 108010086677 Gonadotropins Proteins 0.000 title claims description 20
- 239000002622 gonadotropin Substances 0.000 title claims description 20
- 238000000034 method Methods 0.000 title description 5
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 10
- 239000001509 sodium citrate Substances 0.000 description 10
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 10
- 239000005720 sucrose Substances 0.000 description 10
- 229920001213 Polysorbate 20 Polymers 0.000 description 9
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 9
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 9
- 238000004108 freeze drying Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 229940068977 polysorbate 20 Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 5
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 5
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 5
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229940028334 follicle stimulating hormone Drugs 0.000 description 4
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940094892 gonadotropins Drugs 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- -1 their production Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93201215 | 1993-04-28 | ||
PCT/EP1994/001303 WO1994025005A1 (en) | 1993-04-28 | 1994-04-25 | Lyospheres comprising gonadotropin |
Publications (3)
Publication Number | Publication Date |
---|---|
NO954320D0 NO954320D0 (no) | 1995-10-27 |
NO954320L NO954320L (no) | 1995-10-27 |
NO311168B1 true NO311168B1 (no) | 2001-10-22 |
Family
ID=8213798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19954320A NO311168B1 (no) | 1993-04-28 | 1995-10-27 | Lyosf¶rer omfattende gonadotropin, fremgangsmåte ved fremstilling derav og farmasöytisk preparat omfattende sådanne |
Country Status (16)
Country | Link |
---|---|
US (1) | US5656597A (ja) |
EP (1) | EP0695171B1 (ja) |
JP (1) | JPH08509483A (ja) |
KR (1) | KR100334856B1 (ja) |
AT (1) | ATE146360T1 (ja) |
AU (1) | AU679986B2 (ja) |
CA (1) | CA2150251C (ja) |
DE (1) | DE69401204T2 (ja) |
DK (1) | DK0695171T3 (ja) |
ES (1) | ES2098140T3 (ja) |
FI (1) | FI112324B (ja) |
GR (1) | GR3022510T3 (ja) |
HK (1) | HK1002017A1 (ja) |
NO (1) | NO311168B1 (ja) |
NZ (1) | NZ265956A (ja) |
WO (1) | WO1994025005A1 (ja) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL120202A (en) | 1996-03-07 | 2001-03-19 | Akzo Nobel Nv | Container with freeze-dried vaccine components |
GB2329124B (en) * | 1997-09-12 | 2002-05-08 | Hiran Asoka Malinga Ratwatte | Method of forming dose units of active agents |
AU773556B2 (en) * | 1999-04-05 | 2004-05-27 | Mannkind Corporation | Methods for fine powder formation |
EP1658840A1 (en) * | 1999-04-05 | 2006-05-24 | Mannkind Corporation | Methods for fine powder formation |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
EP1494732B1 (en) | 2002-03-20 | 2008-01-30 | MannKind Corporation | Inhalation apparatus |
US20040248784A1 (en) * | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
US20060222694A1 (en) * | 2003-06-27 | 2006-10-05 | Oh Choon K | Stabilized topotecan liposomal composition and methods |
KR101273120B1 (ko) | 2004-08-20 | 2013-06-13 | 맨카인드 코포레이션 | 다이케토피페라진 합성의 촉매 작용 |
KR20130066695A (ko) | 2004-08-23 | 2013-06-20 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
IN2014DN09128A (ja) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
TWI436789B (zh) | 2008-01-21 | 2014-05-11 | Intervet Int Bv | 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包 |
CA2716399C (en) | 2008-03-05 | 2020-07-21 | Pierre Chouvenc | Process for stabilizing an adjuvant containing vaccine composition |
CN101269215B (zh) * | 2008-05-15 | 2011-03-23 | 上海天伟生物制药有限公司 | 一种糖蛋白激素组合物 |
CN109568740B (zh) | 2008-06-13 | 2022-05-27 | 曼金德公司 | 干粉吸入器和用于药物输送的*** |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
ES2904623T3 (es) | 2008-06-20 | 2022-04-05 | Mannkind Corp | Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
KR20130117755A (ko) | 2010-06-21 | 2013-10-28 | 맨카인드 코포레이션 | 건조 분말 약물 운반 시스템 및 방법 |
JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
BR112014009686A2 (pt) | 2011-10-24 | 2018-08-07 | Mannkind Corp | composição analgésica inalável, pó seco e método para tratar dor |
AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
ES2754388T3 (es) | 2013-03-15 | 2020-04-17 | Mannkind Corp | Composiciones y métodos de dicetopiperazina microcristalina |
WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US10617650B2 (en) * | 2015-10-16 | 2020-04-14 | Merck Sharp & Dohme Corp. | Process for preparing formulations for gastrointestinal-targeted therapies |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932943A (en) * | 1970-08-14 | 1976-01-20 | E. I. Du Pont De Nemours And Company | Method of preparation of lyophilized biological products |
ATE14047T1 (de) * | 1981-12-11 | 1985-07-15 | Wyeth John & Brother Ltd | Verfahren und vorrichtung zum gefrieren einer fluessigkeit. |
JPS60258125A (ja) * | 1984-06-06 | 1985-12-20 | Hayashibara Biochem Lab Inc | 蛋白性生理活性物質を含有する水溶性乾燥物 |
CA2030551C (en) * | 1989-05-01 | 1998-08-25 | Wayne Gombotz | Process for producing small particles of biologically active molecules |
IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
-
1994
- 1994-04-25 JP JP6523868A patent/JPH08509483A/ja active Pending
- 1994-04-25 ES ES94915121T patent/ES2098140T3/es not_active Expired - Lifetime
- 1994-04-25 NZ NZ265956A patent/NZ265956A/en not_active IP Right Cessation
- 1994-04-25 EP EP94915121A patent/EP0695171B1/en not_active Expired - Lifetime
- 1994-04-25 AT AT94915121T patent/ATE146360T1/de active
- 1994-04-25 AU AU66488/94A patent/AU679986B2/en not_active Ceased
- 1994-04-25 WO PCT/EP1994/001303 patent/WO1994025005A1/en active IP Right Grant
- 1994-04-25 KR KR1019950702180A patent/KR100334856B1/ko not_active IP Right Cessation
- 1994-04-25 CA CA002150251A patent/CA2150251C/en not_active Expired - Fee Related
- 1994-04-25 DE DE69401204T patent/DE69401204T2/de not_active Expired - Lifetime
- 1994-04-25 DK DK94915121.1T patent/DK0695171T3/da active
- 1994-04-25 US US08/454,333 patent/US5656597A/en not_active Expired - Lifetime
-
1995
- 1995-07-14 FI FI953442A patent/FI112324B/fi not_active IP Right Cessation
- 1995-10-27 NO NO19954320A patent/NO311168B1/no not_active IP Right Cessation
-
1997
- 1997-02-11 GR GR970400207T patent/GR3022510T3/el unknown
-
1998
- 1998-02-11 HK HK98101026A patent/HK1002017A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ265956A (en) | 1996-09-25 |
US5656597A (en) | 1997-08-12 |
NO954320D0 (no) | 1995-10-27 |
FI953442A0 (fi) | 1995-07-14 |
GR3022510T3 (en) | 1997-05-31 |
DK0695171T3 (da) | 1997-06-02 |
DE69401204D1 (de) | 1997-01-30 |
ES2098140T3 (es) | 1997-04-16 |
FI112324B (fi) | 2003-11-28 |
EP0695171A1 (en) | 1996-02-07 |
EP0695171B1 (en) | 1996-12-18 |
AU679986B2 (en) | 1997-07-17 |
AU6648894A (en) | 1994-11-21 |
CA2150251A1 (en) | 1994-11-10 |
NO954320L (no) | 1995-10-27 |
HK1002017A1 (en) | 1998-07-24 |
KR950703934A (ko) | 1995-11-17 |
DE69401204T2 (de) | 1997-06-05 |
KR100334856B1 (ko) | 2002-11-07 |
WO1994025005A1 (en) | 1994-11-10 |
FI953442A (fi) | 1995-07-14 |
CA2150251C (en) | 2005-02-22 |
ATE146360T1 (de) | 1997-01-15 |
JPH08509483A (ja) | 1996-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO311168B1 (no) | Lyosf¶rer omfattende gonadotropin, fremgangsmåte ved fremstilling derav og farmasöytisk preparat omfattende sådanne | |
DE69813322T2 (de) | Flüssige gonadotropinhaltige Arzneimittel | |
US20210244669A1 (en) | Formulations and methods for lyophilization and lyophilates provided thereby | |
DE69102465T2 (de) | Stabilisierte Gonadotropin enthaltende Zubereitungen. | |
EP2598160B1 (en) | Stabilization of fsh | |
DE202009009905U1 (de) | Flüssig-Formulierung von FSH | |
JPH08507064A (ja) | 有機溶媒を用いて処理したポリペプチドの賦形剤安定化 | |
JP3702313B2 (ja) | ゴナドトロピン含有薬剤組成物 | |
Deguettes et al. | Controlled delivery of follicle-stimulating hormone in cattle | |
US5384132A (en) | Stabilized gonadotropin containing preparations | |
Yang et al. | Effects of a gonadotropin releasing hormone agonist on oocyte maturation, fertilization, and embryonal development in mice | |
DE69105114T2 (de) | Methode zur erhöhung der fruchtbarkeit weiblicher säuger. | |
Wagner et al. | Failure of USP tablet disintegration test to predict performance in man | |
Xiao et al. | Human placenta and fetal membranes contain peptide YY1-36 and peptide YY3-36 | |
Moes et al. | Arginine stimulated glucagon and insulin secretion by islets of Langerhans of pregnant and lactating rats | |
WO1995022342A1 (en) | Pharmaceutical formulations of ciliary neurotrophic factor | |
Howles | The r-hFSH Doses: Gonadotropins Which or u-hFSH, Protocol Biosimilars, in IVF Regimens | |
CN116270965A (zh) | 稳定化西曲瑞克冻干组合物的方法和组合物 | |
TW202421098A (zh) | 口服多肽調配物 | |
CN109125307A (zh) | 一种克罗米酚-多肽复合物、药物制剂及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |